Subtopic Deep Dive

DNA Binding Mechanisms of Ecteinascidin
Research Guide

What is DNA Binding Mechanisms of Ecteinascidin?

DNA binding mechanisms of ecteinascidin refer to the covalent alkylation of guanine N2 in the DNA minor groove and non-covalent interactions that bend DNA toward the major groove, exhibiting sequence selectivity for antitumor activity.

Ecteinascidin 743 (ET-743) binds covalently to the N2 position of guanine in the minor groove via its carbinolamine group (Pommier et al., 1996, 293 citations). This binding induces DNA bending toward the major groove and interferes with transcription factor binding (Zewail-Foote and Hurley, 1999, 203 citations; Minuzzo et al., 2000, 195 citations). Over 10 key papers document these mechanisms using biochemical assays, crystallography, and clinical correlations.

Curated Papers

Key Challenges

Why It Matters

Precise understanding of ecteinascidin's minor groove alkylation enables design of analogs with improved cancer selectivity, as shown in phthalascidin's comparable potency (Martínez et al., 1999, 169 citations). Clinical efficacy in refractory soft tissue sarcomas links binding specificity to therapeutic outcomes (García-Carbonero et al., 2004, 292 citations). These mechanisms underpin structure-activity relationships for marine alkaloid derivatives in oncology trials (Erba et al., 2001, 255 citations).

Key Research Challenges

Sequence Specificity Determination

Identifying exact DNA sequences preferred by ecteinascidin for guanine N2 alkylation remains challenging due to variable minor groove conformations. Pommier et al. (1996) mapped selectivity but computational prediction lags experimental validation. Advanced NMR and crystallography are needed for broader sequence contexts.

DNA Bending Quantification

Quantifying the extent and direction of DNA bending toward the major groove by ecteinascidin requires high-resolution structural data. Zewail-Foote and Hurley (1999) described bending but dynamic simulations are limited. Integrating computational modeling with biophysical assays addresses this gap.

Toxicity Reduction Strategies

Decoupling covalent binding potency from off-target toxicity hinders analog development for clinical use. Erba et al. (2001) highlighted unique mechanisms but selectivity improvements are slow. Phthalascidin analogs show promise yet need refined SAR studies (Martínez et al., 1999).

Essential Papers

Marine natural products

John W. Blunt, Anthony R. Carroll, Brent R. Copp et al. · 2018 · Natural Product Reports · 718 citations

This review of 2016 literature describes the structures and biological activities of 1277 new marine natural products and the structure revision and absolute configuration of previously reported MN...

Marine natural products and their potential applications as anti-infective agents

Marwa S. Donia, Mark T. Hamann · 2003 · The Lancet Infectious Diseases · 422 citations

DNA Sequence- and Structure-Selective Alkylation of Guanine N2 in the DNA Minor Groove by Ecteinascidin 743, a Potent Antitumor Compound from the Caribbean Tunicate <i>Ecteinascidia turbinata</i>

Yves Pommier, Glenda Kohlhagen, Christian Bailly et al. · 1996 · Biochemistry · 293 citations

Ecteinascidin 743 is one of several related marine alkaloids isolated from the Caribbean tunicate Ecteinascidia turbinata. It is remarkably active and potent in a variety of in vitro and in vivo sy...

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Rocio García‐Carbonero, Jeff Supko, Judith Manola et al. · 2004 · Journal of Clinical Oncology · 292 citations

Purpose To assess the efficacy of the marine-derived alkaloid ecteinascidin 743 (ET-743) in patients with soft tissue sarcomas that progressed despite prior conventional chemotherapy and to charact...

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action

Eugenio Erba, Daniele Bergamaschi, L Bassano et al. · 2001 · European Journal of Cancer · 255 citations

Ecteinascidin 743: A Minor Groove Alkylator That Bends DNA toward the Major Groove

Maha Zewail‐Foote, Laurence H. Hurley · 1999 · Journal of Medicinal Chemistry · 203 citations

The ecteinascidins (Ets), which are natural products derived from marine tunicates, exhibit potent antitumor activity. Of the numerous Ets isolated, Et 743 is presently being evaluated in phase II ...

Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743

Mario Minuzzo, Sergio Marchini, Massimo Broggini et al. · 2000 · Proceedings of the National Academy of Sciences · 195 citations

Ecteinascidin-743 (ET-743) is a tetrahydroisoquinoline alkaloid isolated from the tunicate Ecteinascidia turbinata currently under phase II clinical trials for its potent anticancer activity. ET-74...

Reading Guide

Foundational Papers

Start with Pommier et al. (1996, 293 citations) for core alkylation mechanism and sequence selectivity; follow with Zewail-Foote and Hurley (1999, 203 citations) for DNA bending details; Erba et al. (2001, 255 citations) links to biological activity.

Recent Advances

Blunt et al. (2018, 718 citations) reviews marine natural products including ecteinascidin analogs; García-Carbonero et al. (2004, 292 citations) provides clinical binding correlations.

Core Methods

Covalent alkylation assays target guanine N2; gel electrophoresis quantifies bending; transcription factor interference assays assess functional impact; computational docking models minor groove fit.

How PapersFlow Helps You Research DNA Binding Mechanisms of Ecteinascidin

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to trace foundational works like Pommier et al. (1996, 293 citations) and its 200+ citing papers on ecteinascidin alkylation. exaSearch uncovers sequence-specific binding studies, while findSimilarPapers reveals analogs like phthalascidin (Martínez et al., 1999).

Analyze & Verify

Analysis Agent employs readPaperContent on Zewail-Foote and Hurley (1999) to extract DNA bending metrics, then verifyResponse with CoVe checks claims against raw abstracts. runPythonAnalysis parses binding affinity data from Pommier et al. (1996) using pandas for statistical verification; GRADE grading scores evidence strength for minor groove selectivity.

Synthesize & Write

Synthesis Agent detects gaps in sequence specificity coverage across Erba et al. (2001) and Minuzzo et al. (2000), flagging contradictions in bending models. Writing Agent uses latexEditText and latexSyncCitations to draft SAR sections with 10+ references, latexCompile for figure-inclusive reports, and exportMermaid for DNA binding diagrams.

Use Cases

"Extract and plot guanine alkylation rates from ecteinascidin binding papers."

Research Agent → searchPapers('ecteinascidin DNA alkylation') → Analysis Agent → readPaperContent(Pommier 1996) → runPythonAnalysis(pandas plot of N2 rates) → matplotlib graph of sequence selectivity.

"Write LaTeX review of ecteinascidin minor groove mechanisms with citations."

Synthesis Agent → gap detection(Erba 2001, Zewail-Foote 1999) → Writing Agent → latexEditText(structure-activity draft) → latexSyncCitations(10 papers) → latexCompile(PDF with binding diagrams).

"Find code for simulating ecteinascidin-DNA docking."

Research Agent → searchPapers('ecteinascidin computational modeling') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(DNA docking scripts) → runPythonAnalysis(test simulation).

Automated Workflows

Deep Research workflow scans 50+ papers via citationGraph from Pommier et al. (1996), generating structured reports on binding evolution with GRADE-scored sections. DeepScan applies 7-step CoVe analysis to verify bending claims in Zewail-Foote and Hurley (1999), checkpointing against Minuzzo et al. (2000). Theorizer synthesizes novel hypotheses on sequence selectivity from Erba et al. (2001) and analogs.

Try Doxa for DNA Binding Mechanisms of Ecteinascidin Research

Frequently Asked Questions

What is the primary DNA binding mode of ecteinascidin?

Ecteinascidin 743 alkylates guanine N2 in the minor groove covalently while forming non-covalent hydrogen bonds, as detailed in Pommier et al. (1996).

What methods study ecteinascidin-DNA interactions?

Biochemical alkylation assays, gel mobility shifts for bending, and transcription interference measure binding; NMR and crystallography provide structures (Zewail-Foote and Hurley, 1999; Minuzzo et al., 2000).

Which are key papers on ecteinascidin mechanisms?

Pommier et al. (1996, 293 citations) on sequence-selective alkylation; Zewail-Foote and Hurley (1999, 203 citations) on minor groove bending; Erba et al. (2001, 255 citations) on unique action.

What open problems exist in ecteinascidin binding research?

Predicting full sequence specificity beyond known motifs, quantifying dynamic bending in vivo, and engineering low-toxicity analogs remain unresolved (Martínez et al., 1999).